Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012

Pediatrics

Volumn 131, Issue 6, 2013, Pages 1042-1049

  Haber, Penina ^a   Patel, Manish ^b   Pan, Yi ^a   Baggs, James ^a   Haber, Michael ^c   Museru, Oidda ^a   Yue, Xin ^a   Lewis, Paige ^a   DeStefano, Frank ^a   Parashar, Umesh D ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Adverse event; Intussusception; Rotavirus vaccines; Safety monitoring; VAERS

Indexed keywords

BARIUM; ROTAVIRUS VACCINE;

ARTICLE; AUTOPSY; BARIUM ENEMA; DOSAGE SCHEDULE COMPARISON; DRUG FATALITY; DRUG MONITORING; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; INTESTINE SURGERY; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PRIORITY JOURNAL; REMISSION; RISK; RISK ASSESSMENT; ROTAVIRUS INFECTION; SENSITIVITY ANALYSIS;

ADVERSE EVENT; INTUSSUSCEPTION; ROTAVIRUS VACCINES; SAFETY MONITORING; VAERS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; INFANT; INTUSSUSCEPTION; RISK; RISK ASSESSMENT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 84878698717     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-2554     Document Type: Article

References (26)

1. Murphy TV, Gargiullo PM, Massoudi MS, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine [published correction appears in N Engl J Med. 2001;344 (20)1564]. N Engl J Med. 2001;344(8):564-572 (Pubitemid 32167870)
2. Vesikari T, Matson DO, Dennehy P, et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354 (1):23-33 (Pubitemid 43048948)
3. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22 (Pubitemid 43048947)
4. Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13
5. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med. 2011; 365(12):1108-1117
6. Buttery JP, Danchin MH, Lee KJ, et al; PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29(16):3061-3066
7. Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24): 2283-2292
8. Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012;307(6):598-604
9. Belongia EA, Irving SA, Shui IM, et al; Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1-5
10. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121(6):1206-1212
11. Food and Drug Administration. 21CFR Part 600.80. Postmarketing reporting of adverse experiences. Fed Regist. 1997;62: 52252-52253
12. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23(4): 287-294 (Pubitemid 38508877)
13. Medical Dictionary for Regulatory Activities. Available at www.meddramsso.com. Accessed June 7, 2012
14. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85(12):1706-1709 (Pubitemid 26002609)
15. Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team. Enhancing vaccine safety surveillance: a capturerecapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol. 2001; 154(11):1006-1012 (Pubitemid 33121618)
16. Bines JE, Kohl KS, Forster J, et al; Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22(5-6):569-574 (Pubitemid 38114883)
17. Glanz JM, McClure DL, Xu S, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006; 59(8):808-818 (Pubitemid 43996937)
18. Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012; 30(11):2024-2031
19. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-1797
20. Escolano S, Farrington CP, Hill C, Tubert- Bitter P. Intussusception after rotavirus vaccination-spontaneous reports. N Engl J Med. 2011;365(22):2139
21. Haber P, Patel M, Baggs J, Parashar U. Post-licensure Safety Monitoring of Rota- Teq Vaccine in the United States, Vaccine Adverse Event Reporting System, 2006-2010 [Abstract: ]. Presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 18, 2011; Chicago, IL
22. Centers for Disease Control and Prevention. 2011 Table Data. Available at www.cdc.gov/vaccines/stats-surv/nis/data/tables-2011.htm. Accessed February 3, 2013
23. Desai R, Cortese MM, Meltzer MI, et al. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Pediatr Infect Dis J. 2013;32(1):1-7
24. Tate JE, Simonsen L, Viboud C, et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 2008;121 (5). Available at: www.pediatrics.org/cgi/content/full/121/5/e1125
25. Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect. 2011;139(12):1805-1817
26. Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis. 2012;206(1):41-48